Symbolbild · KI-generiert
Avita Medical
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. We do not have a verified market capitalisation for this company.
Company profile
Avita Medical is a medical technology company that has developed and commercialised a regenerative skin therapy system called RECELL. The system enables the treatment of burns and skin injuries using the patient's own skin cells and is approved primarily in the United States.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Avita Medical | AVH | ASX | 135 Mio. USD |
| HealWELL AI Inc. | AIDX | TSX | 141 Mio. USD |
| Cardiol Therapeutics Inc. | CRDL | TSX | 145 Mio. USD |
| Custom Health Holdings Inc. | CHLT | TSX | 122 Mio. USD |
| BioSyent Inc. | RX | TSXV | 121 Mio. USD |
| DIRTT Environmental Solutions Ltd. | DRT | TSX | 120 Mio. USD |
| Hydreight Technologies Inc. | NURS | TSXV | 153 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.